Transcept Pharmaceuticals, Inc. Condensed Consolidated Balance Sheets (in thousands) | |||||
March 31, | December 31, | ||||
2011 | 2010 | ||||
Assets | (Unaudited) | ||||
Current assets: | |||||
Cash and cash equivalents | $ 3,607 | $ 13,720 | |||
Marketable securities | 59,680 | 54,251 | |||
Other current assets | 1,662 | 1,452 | |||
Total current assets | 64,949 | 69,423 | |||
Property and equipment, net | 511 | 614 | |||
Goodwill | 2,962 | 2,962 | |||
Other assets | 808 | 808 | |||
Total assets | $ 69,230 | $ 73,807 | |||
Liabilities and stockholders' equity | |||||
Current liabilities: | |||||
Deferred revenue, current portion | $ 4,167 | $ 7,292 | |||
Other current liabilities | 2,141 | 2,356 | |||
Total current liabilities | 6,308 | 9,648 | |||
Other non-current liabilities | 261 | 348 | |||
Total liabilities | 6,569 | 9,996 | |||
Stockholders' equity: | |||||
Common stock and additional paid-in capital | 160,797 | 160,023 | |||
Accumulated deficit | (98,153) | (96,214) | |||
Accumulated other comprehensive income | 17 | 2 | |||
Total stockholders' equity | 62,661 | 63,811 | |||
Total liabilities and stockholders' equity | $ 69,230 | $ 73,807 | |||
